Solomon Park Research Laboratories, Inc.

Burien, WA

UEI
JALQHUNRVAL9
CAGE
3XYY2
Primary NAICS
325413 In-Vitro Diagnostic Substance Manufacturing
SAM.gov registration
Active through

Company facts

FY2025 rankings
Self-certified in SAM.gov
  • For Profit Organization
  • Veteran Owned Business
  • Manufacturer of Goods
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
658 S 152nd St, Burien, WA 98148, USA
Website
solomon.org
Founded
1984
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $135,835
FY2025 $273,720
FY2024 $328,825
FY2023 -$8,401

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Commerce $135,835

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Contract subawards

Prime contractor Prime award Amount Awarded
Impres Technology Solutions, Inc. CORONARY ARTERY RISK DEVELOPMENT IN YOUNG ADULTS (CARDIA) STUDY - COORDINATING CENTER (CC) The specific objectives of this contract are for the Central Blood… 75N92023F00001 $43,079

Grant subawards

Prime recipient Prime award Amount Awarded
The Johns Hopkins University Utilizing islet autoantibody signatures for precision medicine in type 2 diabetes R01DK126825 $53,334

Similar vendors

About the company

Solomon Park Research Laboratories, Inc., a veteran-owned small business headquartered in Burien, Washington, manufactures human blood serum and plasma Standard Reference Materials (SRM) and reference specimens for federal biomedical research, disease diagnostics, and laboratory standardization as a prime contractor under total small business set-asides. The company operates almost exclusively as a prime (96% of recent awards) and competes through simplified acquisition procedures and small-business set-asides rather than on full-and-open vehicles; no parent IDIQs or GWACs appear in its footprint.

Solomon Park's customer concentration aligns heavily with the Department of Health and Human Services. The top three funding agencies account for 88% of recent awards: the Centers for Disease Control and Prevention Office of Acquisition Services (10 awards, $18.1 million combined potential value), the CDC Pittsburgh laboratory division (14 awards, $2.3 million), and the National Institute of Standards and Technology (20 awards, $1.5 million). The dollar rankings diverge from award count — NIST places the most orders (primarily small purchase orders under $300,000 each for SRM production), but CDC's Office of Acquisition Services anchors the largest single commitments, including multi-year specimen collection and storage contracts. Recent prime work includes a $273,720 purchase order from NIST (September 2025) to produce four pools of human serum SRM 972d with vitamin D metabolites, a $202,000 firm-fixed-price order (September 2024) for SRM 1950a Metabolites in Frozen Human Plasma (20,000 vials), and a $126,825 delivery of Frozen Human Serum SRM 909d (August 2024).

Solomon Park's work clusters in testing laboratories and biological product manufacturing. The top NAICS categories are 541380 (Testing Laboratories and Services, 13 awards) and 325414 (Biological Product except Diagnostic Manufacturing, 11 awards), with secondary work under in-vitro diagnostic substance manufacturing (NAICS 325413, 6 awards). PSC codes track as Drugs and Biologicals and Laboratory Equipment and Supplies (14 awards each). The company's capability footprint centers on pooled human serum and plasma specimen production, biosafety testing, ISO 13485:2016 compliance, long-term cryogenic storage protocol, and material certification to CLSI C37-A guidelines — work that directly supports NIST metrology missions and CDC epidemiological studies. Activity has been episodic; after steady volume in 2020 (five awards), the award cadence dropped to one or fewer awards per year in 2021, 2024, 2025, and 2026, with combined potential value across all fifty-two awards reaching $33.9 million (dollars obligated $6.9 million). One award (combined potential value $136 thousand) faces completion inside the next twenty-four months. Solomon Park subcontracts minimally; recent sub work includes specimen storage and sample logging support to Impres Technology Solutions on the Coronary Artery Risk Development in Young Adults (CARDIA) Study Coordinating Center, and a Johns Hopkins University-led grant focusing on islet autoantibody signatures in type 2 diabetes.

Quick answers

Is Solomon Park Research Laboratories, Inc. registered in SAM.gov?

Yes. Solomon Park Research Laboratories, Inc.'s SAM.gov registration is active through June 2, 2027.

How much has Solomon Park Research Laboratories, Inc. received in federal contracts?

Federal contracts obligated $273,720 to Solomon Park Research Laboratories, Inc. in fiscal year 2025 and $729,979 in fiscal years 2023 through 2027.

How does Solomon Park Research Laboratories, Inc. rank among federal contractors?

Solomon Park Research Laboratories, Inc. ranked #35 in NAICS 325414 in FY2025.

What is Solomon Park Research Laboratories, Inc.'s most recent federal award?

Solomon Park Research Laboratories, Inc.'s most recent federal contract award is OU63-FY26-275-new human serum standard reference material (SRM) (1333ND26PNB640303), from National Institute of Standards and Technology, on August 17, 2026.

On GovTribe

See Solomon Park Research Laboratories, Inc.'s full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors